References
- Zhang J, Huang Y, Liu D, et al. Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement. Eur J Pharm Sci. 2013;48:740–747.
- Ding SM, Zhang ZH, Song J, et al. Enhanced bioavailability of apigenin via preparation of a carbon nanopowder solid dispersion. Int J Nanomedicine. 2014;9:2327–2333.
- Zhai Y, Guo S, Liu C, et al. Preparation and in vitro evaluation of apigenin-loaded polymeric micelles. Colloids Surf A: Physicochem Eng Aspects. 2013;429:24–30.
- Shen L-N, Zhang Y-T, Wang Q, et al. Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. Int J Pharm. 2014;460:280–288.
- Duchěne D, Wouessidjewe D. Pharmaceutical uses of cyclodextrins and derivatives. Drug Dev Ind Pharm. 2008;16:2487–2499.
- Zhao X, Wang Z, Li X. Preparation, in-vitro release and antioxidant potential of formulation of apigenin with hydroxypropyl-β-cyclodextrin modified microemulsion. J Incl Phenom Macrocycl Chem. 2016;86:1–10.
- Sanghavi NM, Mayekar R, Fruitwala M. Inclusion complexes of terfenadine-cyclodextrins. Drug Dev Ind Pharm. 2008;21:375–381.
- Zu Y, Wu W, Zhao X, et al. The high water solubility of inclusion complex of taxifolin-γ-CD prepared and characterized by the emulsion solvent evaporation and the freeze drying combination method. Int J Pharm. 2014;477:148–158.
- Kim H, Kim HW, Jung S. Aqueous solubility enhancement of some flavones by complexation with cyclodextrins. Bull Korean Chem Soc. 2008;29:590–594.
- Li J. Study and characterization of the antioxidant activity of the inclusion complex of apigenin with beta-cyclodextrin and HP-beta-cyclodextrin in solution. J Invest Biochem. 2014;3:107.
- Pápay ZE, Sebestyén Z, Ludányi K, et al. Comparative evaluation of the effect of cyclodextrins and pH on aqueous solubility of apigenin. J Pharm Biomed Anal. 2016;117:210–216.
- Huang Y, Zu Y, Zhao X, et al. Preparation of inclusion complex of apigenin-hydroxypropyl-β-cyclodextrin by using supercritical antisolvent process for dissolution and bioavailability enhancement. Int J Pharm. 2016;511:921–930.
- Wang Z, Chen JF, Le Y, et al. Preparation of ultrafine beclomethasone dipropionate drug powder by antisolvent precipitation. Ind Eng Chem Res. 2007;46:4839–4845.
- Luo X, Xu YH, Chen B, et al. Solubilization on cryptotanshinone by hydroxypropyl-beta-cyclodextrin and preparation of their inclusion compound. Zhongguo Zhong Yao Za Zhi. 2005;30:1328–1331.
- Chen XY, Liu WY, Zhang J. Study on the characterization of beta-cyclodextrin-diferrocenylenone inclusion complex and micro-environmental effects. Guang Pu Xue Yu Guang Pu Fen Xi. 2006;26:1285–1289.
- Ji MH, Shu HM, Guo FY, et al. Study on the preparation process of inclusion complex of volatile oil of Dalbergia odorifera-beta-cyclodextrin. Zhong Yao Cai. 2009;32:114–117.
- Ahn BK, Lee SG, Kim SR, et al. Inclusion compound formulation of hirsutenone with beta-cyclodextrin. J Pharm Invest. 2013;43:453–459.
- Li B, Robinson DH, Birt DF. Evaluation of properties of apigenin and [G-3H]apigenin and analytic method development. J Pharm Sci. 1997;86:721–725.
- Romero S, Escalera B, Bustamante P. Solubility behavior of polymorphs I and II of mefenamic acid in solvent mixtures. Int J Pharm. 1999;178:193–202.
- Park Y, Lee J, Sun HL, et al. Crystal structures of tetramorphic forms of donepezil and energy/temperature phase diagram via direct heat capacity measurements. Cryst Growth Des. 2013;13:5450–5458.
- Zhu WZ, Wang JX, Shao L, et al. Liquid antisolvent preparation of amorphous cefuroxime axetil nanoparticles in a tube-in-tube microchannel reactor. Int J Pharm. 2010;395:260–265.
- Zhang HX, Wang JX, Zhang ZB, et al. Micronization of atorvastatin calcium by antisolvent precipitation process. Int J Pharm. 2009;374:106–113.
- Zhang J, Liu D, Huang Y, et al. Biopharmaceutics classification and intestinal absorption study of apigenin. Int J Pharm. 2012;436:311–317.